Kathryn Guarini insider trades
Open-market stock purchases and sales by Kathryn Guarini, Director at Regeneron Pharmaceuticals, Inc, from SEC Form 4 filings since Sep 8, 2023.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 2, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $340K |
| Sep 2, 2026 | REGN Regeneron Pharmaceuticals, Inc | Bought (not open market) | — |
| Aug 10, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $320K |
| Aug 10, 2026 | REGN Regeneron Pharmaceuticals, Inc | Bought (not open market) | — |
| Jan 2, 2026 | REGN Regeneron Pharmaceuticals, Inc | Bought (not open market) | — |
| Jan 2, 2026 | REGN Regeneron Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- REGN Regeneron Pharmaceuticals, Inc: 2 sales, last Sep 2, 2026